| NCAM1 |
NCAM1, NCAM: Neural cell adhesion molecule 1, 140 kDa isoform precursor |
MAPK8IP1 |
MAPK8IP1, IB1, JIP1, PRKM8IP: C-jun-amino-terminal kinase-interacting protein 1 |
0.295 |
Evidence |
|
| NCAM1 |
NCAM1, NCAM: Neural cell adhesion molecule 1, 140 kDa isoform precursor |
PRKCZ |
PRKCZ, PKC2: Protein kinase C zeta type |
0.295 |
Evidence |
|
| NCAM1 |
NCAM1, NCAM: Neural cell adhesion molecule 1, 140 kDa isoform precursor |
FGF9 |
FGF9: Glia-activating factor precursor |
0.295 |
Evidence |
|
| CCL5 |
CCL5, D17S136E, SCYA5: Small-inducible cytokine A5 precursor |
CD69 |
CD69: Early activation antigen CD69 |
0.295 |
Evidence |
|
| CCL5 |
CCL5, D17S136E, SCYA5: Small-inducible cytokine A5 precursor |
ICAM3 |
ICAM3: Intercellular adhesion molecule 3 precursor |
0.295 |
Evidence |
|
| CD79A |
CD79A, IGA, MB1: B-cell antigen receptor complex-associated protein alpha-chain |
VIL2 |
IPI00479359 |
0.295 |
Evidence |
|
| MS4A1 |
MS4A1, CD20: B-lymphocyte antigen CD20 |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
0.295 |
Evidence |
|
| MS4A1 |
MS4A1, CD20: B-lymphocyte antigen CD20 |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
0.295 |
Evidence |
|
| MS4A1 |
MS4A1, CD20: B-lymphocyte antigen CD20 |
CSK |
CSK: Tyrosine-protein kinase CSK |
0.295 |
Evidence |
|
| GHR |
GHR: Growth hormone receptor precursor |
PLD1 |
PLD1: Phospholipase D1 |
0.295 |
Evidence |
|
| CD28 |
CD28: T-cell-specific surface glycoprotein CD28 precursor |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
0.295 |
Evidence |
|
| HLA-C |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
0.295 |
Evidence |
|
| HLA-C |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor |
PTPN12 |
PTPN12: Tyrosine-protein phosphatase non-receptor type 12 |
0.295 |
Evidence |
|
| HLA-C |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor |
NCF1 |
Neutrophil cytosolic factor 1 variant (Fragment) |
0.295 |
Evidence |
|
| C1S |
C1S: Complement C1s subcomponent precursor |
LRP1 |
LRP1, A2MR, APR: Prolow-density lipoprotein receptor-related protein 1 precursor |
0.295 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
CRLF3 |
IPI00295387 |
0.295 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
HLA-DMB |
HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec |
0.295 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
CD58 |
CD58, LFA3: Lymphocyte function-associated antigen 3 precursor |
0.295 |
Evidence |
|
| CD3G |
CD3G, T3G: T-cell surface glycoprotein CD3 gamma chain precursor |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
0.295 |
Evidence |
|
| CD3G |
CD3G, T3G: T-cell surface glycoprotein CD3 gamma chain precursor |
PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
0.295 |
Evidence |
|
| CD7 |
CD7: T-cell antigen CD7 precursor |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
0.295 |
Evidence |
|
| CD7 |
CD7: T-cell antigen CD7 precursor |
IQGAP1 |
IQGAP1, KIAA0051: Ras GTPase-activating-like protein IQGAP1 |
0.295 |
Evidence |
|
| CD7 |
CD7: T-cell antigen CD7 precursor |
NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
0.295 |
Evidence |
|
| LGALS1 |
LGALS1: Galectin-1 |
MPZL1 |
MPZL1, PZR, UNQ849/PRO1787: Myelin protein zero-like protein 1 precursor |
0.295 |
Evidence |
|
| CXCL1 |
CXCL1, GRO, GRO1, GROA, MGSA, SCYB1: Growth-regulated protein alpha precursor |
MPZL1 |
MPZL1, PZR, UNQ849/PRO1787: Myelin protein zero-like protein 1 precursor |
0.295 |
Evidence |
|